On Friday, the U.S. Food and Drug Administration (FDA) approved AbbVie’s Viekira Pak, a new hepatitis C cure, that will challenge Gilead Sciences’ more expensive cure. Both FDA and Medicaid programs hoped that the new drug would bring some real competition in hepatitis C drug market. However, there wasn’t much improvement, since AbbVie is going to sell a 12-week kit of the new drug for $83,319. … [Read more...]
You are here: Home / Archives for Sovaldi drug